{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T01:05:48Z","timestamp":1778547948390,"version":"3.51.4"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T00:00:00Z","timestamp":1526947200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Styrelsen for Forskning og Innovation (DK)"},{"name":"Novo Nordisk (DK)"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0197001","type":"journal-article","created":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T13:26:59Z","timestamp":1526995619000},"page":"e0197001","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Association between IL-6 production in synovial explants from rheumatoid arthritis patients and clinical and imaging response to biologic treatment: A pilot study"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6852-9985","authenticated-orcid":true,"given":"Martin","family":"Andersen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikael","family":"Boesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Ellegaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalle","family":"S\u00f6derstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niels H.","family":"S\u00f8e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter","family":"Spee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrik G. W.","family":"M\u00f8rch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00f8ren","family":"Torp-Pedersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9302-9678","authenticated-orcid":true,"given":"Else M.","family":"Bartels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bente","family":"Danneskiold-Sams\u00f8e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henning","family":"Bliddal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,5,22]]},"reference":[{"issue":"23","key":"ref1","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"IB McInnes","year":"2011","journal-title":"N Engl J Med"},{"issue":"12","key":"ref2","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1002\/1529-0131(200012)43:12<2619::AID-ANR1>3.0.CO;2-V","article-title":"The pathogenesis and prevention of joint damage in rheumatoid arthritis: advances from synovial biopsy and tissue analysis","volume":"43","author":"PP Tak","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"907","DOI":"10.3899\/jrheum.080592","article-title":"Changing patterns of tumor necrosis factor inhibitor use in 9074 patients with rheumatoid arthritis","volume":"36","author":"Y Yazici","year":"2009","journal-title":"J Rheumatol"},{"issue":"12","key":"ref4","doi-asserted-by":"crossref","first-page":"865","DOI":"10.7326\/0003-4819-144-12-200606200-00003","article-title":"Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial","volume":"144","author":"JM Kremer","year":"2006","journal-title":"Ann Intern Med"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/ard.2010.132134","article-title":"Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis","volume":"70","author":"C Salliot","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/art.37816","article-title":"Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: twelve-month data from a twenty-four-month phase III randomized radiographic study","volume":"65","author":"D van der Heijde","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"6","key":"ref7","doi-asserted-by":"crossref","first-page":"R204","DOI":"10.1186\/ar3537","article-title":"Abatacept with methotrexate versus other biologic agents in treatment of patients with active rheumatoid arthritis despite methotrexate: a network meta-analysis","volume":"13","author":"P Guyot","year":"2011","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/rheumatology\/ker300","article-title":"A personalized medicine approach to biologic treatment of rheumatoid arthritis: a preliminary treatment algorithm","volume":"51","author":"PP Tak","year":"2012","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"ref9","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1136\/annrheumdis-2011-200963","article-title":"Performance of a multi-biomarker score measuring rheumatoid arthritis disease activity in the CAMERA tight control study","volume":"71","author":"MF Bakker","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"ref10","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/annrheumdis-2011-201069","article-title":"Inhibition of plasma IL-6 in addition to maintenance of an efficacious trough level of infliximab associated with clinical remission in patients with rheumatoid arthritis: analysis of the RISING Study","volume":"71","author":"T Takeuchi","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E","article-title":"Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium","volume":"42","author":"M Chabaud","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"8","key":"ref12","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/art.1780350805","article-title":"Inhibition of the production of proinflammatory cytokines and immunoglobulins by interleukin-4 in an ex vivo model of rheumatoid synovitis","volume":"35","author":"P Miossec","year":"1992","journal-title":"Arthritis Rheum"},{"issue":"12","key":"ref13","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1002\/art.1780371202","article-title":"Interleukin-4 inhibits bone resorption through an effect on osteoclasts and proinflammatory cytokines in an ex vivo model of bone resorption in rheumatoid arthritis","volume":"37","author":"P Miossec","year":"1994","journal-title":"Arthritis Rheum"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"R113","DOI":"10.1186\/ar2772","article-title":"Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-alpha, Oncostatin M and response to biologic therapies","volume":"11","author":"EM Moran","year":"2009","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"ref15","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/art.1780400809","article-title":"Development of in vitro model systems for destructive joint diseases: novel strategies for establishing inflammatory pannus","volume":"40","author":"O Schultz","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"R107","DOI":"10.1186\/ar4557","article-title":"Synovial explant inflammatory mediator production corresponds to rheumatoid arthritis imaging hallmarks: a cross sectional study","volume":"16","author":"M Andersen","year":"2014","journal-title":"Arthritis Res Ther"},{"issue":"5 Suppl 39","key":"ref17","first-page":"S93","article-title":"The Disease Activity Score and the EULAR response criteria","volume":"23","author":"J Fransen","year":"2005","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"ref18","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1136\/ard.2007.084459","article-title":"Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate","volume":"68","author":"G Wells","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1055\/s-2008-1027196","article-title":"Quantification of colour Doppler activity in the wrist in patients with rheumatoid arthritis\u2014the reliability of different methods for image selection and evaluation","volume":"29","author":"K Ellegaard","year":"2008","journal-title":"Ultraschall Med"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1546-0096-10-23","article-title":"Comparison of ultrasonography with Doppler and MRI for assessment of disease activity in juvenile idiopathic arthritis: a pilot study","volume":"10","author":"L Laurell","year":"2012","journal-title":"Pediatr Rheumatol Online J"},{"issue":"12","key":"ref21","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/acr.21767","article-title":"Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activity","volume":"64","author":"JR Curtis","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"7","key":"ref22","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1093\/rheumatology\/kes362","article-title":"A multi-biomarker score measures rheumatoid arthritis disease activity in the BeSt study","volume":"52","author":"S Hirata","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"ref23","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/nrrheum.2011.157","article-title":"Validation of new biomarkers in systemic autoimmune diseases","volume":"7","author":"MG Tektonidou","year":"2011","journal-title":"Nat Rev Rheumatol"},{"issue":"8","key":"ref24","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1002\/art.21207","article-title":"The smallest detectable difference and sensitivity to change of magnetic resonance imaging and radiographic scoring of structural joint damage in rheumatoid arthritis finger, wrist, and toe joints: a comparison of the OMERACT rheumatoid arthritis magnetic resonance imaging score applied to different joint combinations and the Sharp\/van der Heijde radiographic score","volume":"52","author":"BJ Ejbjerg","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"11","key":"ref25","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1136\/ard.2010.146068","article-title":"Assessment by MRI of inflammation and damage in rheumatoid arthritis patients with methotrexate inadequate response receiving golimumab: results of the GO-FORWARD trial","volume":"70","author":"PG Conaghan","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"ref26","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.3899\/jrheum.121389","article-title":"Serum interleukin 6 before and after therapy with tocilizumab is a principal biomarker in patients with rheumatoid arthritis","volume":"40","author":"K Shimamoto","year":"2013","journal-title":"J Rheumatol"},{"issue":"9","key":"ref27","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1136\/ard.2006.068064","article-title":"Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab","volume":"66","author":"N Nishimoto","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/art.22461","article-title":"Longitudinal power Doppler ultrasonographic assessment of joint inflammatory activity in early rheumatoid arthritis: predictive value in disease activity and radiologic progression","volume":"57","author":"E Naredo","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"7","key":"ref29","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1136\/ard.2009.126995","article-title":"A 78-joints ultrasonographic assessment is associated with clinical assessments and is highly responsive to improvement in a longitudinal study of patients with rheumatoid arthritis starting adalimumab treatment","volume":"69","author":"HB Hammer","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"ref30","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/ard.61.8.730","article-title":"Addition of interleukin 1 (IL1) and IL17 soluble receptors to a tumour necrosis factor alpha soluble receptor more effectively reduces the production of IL6 and macrophage inhibitory protein-3alpha and increases that of collagen in an in vitro model of rheumatoid synoviocyte activation","volume":"61","author":"G Chevrel","year":"2002","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"ref31","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cyto.2005.11.005","article-title":"The combined effects of anti-TNFalpha antibody and IL-1 receptor antagonist in human rheumatoid arthritis synovial membrane","volume":"32","author":"K Hosaka","year":"2005","journal-title":"Cytokine"},{"issue":"6","key":"ref32","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/1529-0131(200106)44:6<1293::AID-ART221>3.0.CO;2-T","article-title":"The combination of tumor necrosis factor alpha blockade with interleukin-1 and interleukin-17 blockade is more effective for controlling synovial inflammation and bone resorption in an ex vivo model","volume":"44","author":"M Chabaud","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1186\/ar3261","article-title":"Blockade of Toll-like receptor 2 prevents spontaneous cytokine release from rheumatoid arthritis ex vivo synovial explant cultures","volume":"13","author":"SN Ultaigh","year":"2011","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"ref34","doi-asserted-by":"crossref","first-page":"R114","DOI":"10.1186\/ar1994","article-title":"Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists","volume":"8","author":"H Hamdi","year":"2006","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"ref35","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00418-003-0587-3","article-title":"Human osteoclasts express different CXC chemokines depending on cell culture substrate: molecular and immunocytochemical evidence of high levels of CXCL10 and CXCL12","volume":"120","author":"F Grassi","year":"2003","journal-title":"Histochem Cell Biol"},{"issue":"5814","key":"ref36","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1126\/science.1137306","article-title":"Cadherin-11 in synovial lining formation and pathology in arthritis","volume":"315","author":"DM Lee","year":"2007","journal-title":"Science"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0022-1759(96)00067-1","article-title":"Tissue digestion with dispase substantially reduces lymphocyte and macrophage cell-surface antigen expression","volume":"194","author":"AL Ford","year":"1996","journal-title":"J Immunol Methods"},{"issue":"9","key":"ref38","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1002\/art.22849","article-title":"Development of an ex vivo cellular model of rheumatoid arthritis: critical role of CD14-positive monocyte\/macrophages in the development of pannus tissue","volume":"56","author":"T Nozaki","year":"2007","journal-title":"Arthritis Rheum"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0197001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T17:56:09Z","timestamp":1588960569000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0197001"}},"subtitle":[],"editor":[{"given":"Masataka","family":"Kuwana","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,5,22]]},"references-count":38,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0197001","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,22]]}}}